Natalie S Callander

22PUBLICATIONS
104CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyRegenerative medicine (incl. stem cells)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 15, 2026
A Phase I Trial of Iopofosine I 131 and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.

|Apr 21, 2026
Integrating Recent Evidence and Expert Perspectives Into the Management of Multiple Myeloma: Consensus Recommendations From the 2025 Bridging the Gaps Conference.

|Feb 16, 2026
Validation of the 2025 IMS/IMWG risk classification in patients with newly diagnosed multiple myeloma treated with quadruplets and autologous stem cell transplant.

Priyanka Venkatesh, Gayathri Ravi, Binod Dhakal

|Jan 27, 2026
Distinct trajectory of measurable residual disease in t(11;14) myeloma treated with quadruplet therapy.

Susan Bal, Gayathri Ravi, Binod Dhakal

|Apr 23, 2025
Establishing measurable residual disease trajectories for patients on treatment for newly diagnosed multiple myeloma as benchmark for deployment of T-cell redirection therapy.

Susan Bal, Tylan Magnusson, Gayathri Ravi

|Apr 07, 2025
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma.

Smith Giri, Binod Dhakal, Natalie S Callander

Pageof 4

Frequent Collaborators

9 joint publications

Binod Dhakal

7 joint publications

Luciano J Costa

6 joint publications

Bhagirathbhai R Dholaria

5 joint publications

Saurabh Chhabra